Schlüsselwörter - Osteologie Kongress 2012

Schlüsselwörter
1,25-Dihydroxyvitamin D3 P 08
11-β HSD1 V 4.5
25-hydroxyvitamin D P 59, P 60
Acrylic bone cement V 6.7
Advanced Glycation Endproducts
V 1.7, P 35
Adynamische Knochenerkrankung
V 2.6
Affinitätschromatographie P 03
Alendronat P 50, P 53, P 64
Alfacalcidol P 64
Alterstraumatologie P 10
Analgetika P 48
Analytik P 60
Ankylosierende Spondylitis
V 1.3
Antiandrogen V 3.4
Antikörper P 03
Aromatase inhibitors P 30
Arthritis V 4.1
Arthrofibrose P 39
Artificial extracellular matrix
P 02
Aseptische Lockerung P 04
Atorvastatin V 4.6
ß-Catenin P 39
Ballon-Sacroplastie V 3.6
Bildgebung V 1.1, V 6.5, P 05,
P 19, P 49, P 52
Biomechanik P 13
Bisphosphonate V 7.8, P 30,
P 45, P 64
BMD P 64
BMSC V 6.8
Bone growth V 7.1
Bone loss V 7.8, P 30
Bone quality V 7.9
Bone strength V 7.2
Breast cancer V 4.6, P 30
Calcitonin V 4.3
Calcium V 6.6, V 7.1
Carpal Bossing P 19
CD146 V 6.8
CD34+ V 6.8
CD44 V 6.3
Cdc42 V 5.2
Chondroitinsulfat P 02
Chondrosarkom V 1.2, P 29
Chondrozyten P 01, P 09
Cimicifuga racemosa P 06
Colitis V 7.8
Collagen type II P 09
Combination therapy V 3.2
Compliance P 55
Compound A V 4.1
Cortisol V 4.5
Cumarati-Engelmann-Syndrom
P 31
Cytokine V 4.2
Dedifferentiation P 09
Denosumab V 3.3, V 3.4, P 52,
P 54, P 55
Diabetes V 2.3
Dickkopf-1 V 4.6
Differenzierung P 02, P 06
DMSO V 5.4
DNA demethylation V 5.4
DVO-Leitlinie V 3.3
DXA V 7.3, P 21, P 22, P 52
DXL measurements P 22
ELISA P 03, P 18
EPC V 6.8
Epidemiologie P 24
Erosionen P 05
Estradiol P 32
Exostose P 19
Fas V 5.4
Fibroblast growth factor-23
V 2.7
Fibronektin V 4.4, V 5.5, V 5.6
Fraktur V 2.2, V 2.4, V 2.5,
V 3.3, V 3.4, V 3.6, V 3.7,
V 7.2, P 10, P 13, P 14, P 22,
P 23, P 24, P 25, P 26, P 27,
P 28, P 33, P 36, P 41, P 47,
P 52, P 58, P 63, P 64
Frakturrisiko V 7.3
GAGs P 02
GIOP V 4.1, P 45
Glucosaminoglycans P 02
GM-CSF V 6.1
Hämophilie P 36
HCV RNA P 61
HDAC-Inhibitoren V 1.2
Hepatitis c P 62
Histomorphometry P 20
HMSC P 01, P 06, P 08
Homing V 4.7
Hormonstatus P 26
Humanes Wachstumshormon
V 2.6
Hyaluronan P 02
Hydroxyapatit P 18
Hypogonadismus V 2.1
Ibandronat V 2.2, V 7.7, P 12,
P 50
IL-17A V 6.1
Immundefizienz V 2.5
Implantat V 1.4
Inflammation V 2.4, V 3.1, V 4.2
Integrin-Rezeptoren V 5.3, V 5.5
Intramedulläre Stabilisation P 10
Kalkaneus P 16
Kardiovaskuläres Risiko P 40
Körperliches Training V 3.5
Knochenbildung V 4.3, V 5.5
Knochendichte V 3.5, V 4.4,
P 38, P 49, P 63, P 65
Knochenmarker V 7.5, P 07,
P 11, P 53
Knochenmarksödem P 54
Knochenmetabolismus P 37
Knorpelmetabolismus P 37
Kollagen V 5.3
Kortikale Porosität P 52
Kyphoplastie P 15
Leber P 32, P 61, P 62
Lokalisierte Osteoporose P 54
M. Ahlbäck V 7.7, P 12
Makrophagen V 2.4
Malignant bone tumor P 29
Mammakarzinom V 1.2
MAPK V 1.5
Männliche Osteoporose V 2.1,
P 07
Mechanical stimulation V 6.9
Mechanotransduktion V 5.1,
P 46
Menarcheal age V 7.2
Mesenchymale Stammzellen
V 4.2, V 4.5, V 5.1, V 6.2,
V 6.7, V 6.8, P 46
Metastase V 1.2, V 6.3
Mevalonate pathway V 4.6
Microarray V 5.1, P 01
Mikroarchitektur V 7.3, V 7.6
Mineralisation V 6.4
Monocyten V 5.6
Mortalität P 25
Muskel P 43, P 44
Nanoindentation V 7.6
Neovascularization V 6.8
Neurofibromatose P 65
Nierenzellkarzinom V 1.2
OPG V 5.6
Os sacrum V 3.6
Ossifikation (heterotrope) V 3.1
Osteo-integration V 6.7
Osteoblast V 1.7, V 5.2, V 5.4,
V 5.5, V 5.6, V 6.4
OSTEOlOGIE 2012 Basel
Osteocalcin P 18
Osteogenesis imperfecta V 7.5
Osteoimmunologie V 1.5, V 2.5
Osteoklast V 1.5, P 02, P 04, P 11
Osteolyse P 04
Osteonekrose V 7.7, P 12
Osteopenie V 3.4
Osteopetrose P 27
Osteoporose V 1.6, V 2.2, V 2.3,
V 3.3, V 3.7, V 4.5, V 5.1, P 06,
P 07, P 13, P 14, P 15, P 16,
P 17, P 23, P 26, P 33, P 34,
P 36, P 42, P 45, P 48, P 49,
P 51, P 53, P 56, P 57, P 64
Osteosarcoma V 6.3, V 6.5, P 29
Ovarektomie V 1.1, V 1.4
Parathormon V 1.1, V 2.1,
V 4.7, P 45, P 46, P 47
Phosphaturie V 2.7
Photodynamisches Polymer P 10
PMI P 52
Polyethylenpartikel P 04
PPD P 01
Progressive diaphysäre Dysplasie
P 31
Proliferation V 6.2
Prostatakarzinom V 3.4
Prothesenlockerung P 11
Quality of Life P 53
Radius P 52
Raloxifen V 2.2
RANKL/OPG-Ratio P 40
Referenzdaten P 44
Regeneration V 3.1
Rehabilitation P 41
Rekombinante Proteinexpression
P 01, P 03
Renal proximal tubules V 2.7
Renale Osteodystrophie P 35
Reposition P 15
RGD Domäne V 5.5
Rheumatoide Arthritis V 6.1,
P 05, P 37, P 40
Risikofaktor P 21, P 22, P 28
Salvage Procedure P 27
SAOS-2 P 06
Sarkopenie P 17
Schmerz V 3.6, P 41, P 48
Schwangerschaft P 33, P 34
Sclerostin-Antikörper V 2.3
Seneszenz P 08
Sexualhormone P 07
Sgp130 P 40
Signaling V 6.2
© Schattauer 2012 Osteologie 1/2012
Downloaded from www.osteologie-journal.de on 2012-04-04 | IP: 77.182.155.2
For personal or educational use only. No other uses without permission. All rights reserved.
A 51